Aprea Therapeutics, Inc. (APRE) NASDAQ
0.76
-0.0517(-6.34%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.76
-0.0517(-6.34%)
Currency In USD
| Market Cap | 5.58M |
| Enterprise Value | -9.02M |
| P/E Ratio | -0.49 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 42.02 |
| Price/Book Ratio | 0.14 |
| Enterprise/Revenue | -351.39 |
| Enterprise/EBITDA | 3.31 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -101.22 |
| Operating Margin | -106.5 |
| Return On Assets | -0.25 |
| Return On Equity | -0.6 |
| Revenue | 0 |
| Revenue/Share | 0.02 |
| Gross Profit | 0 |
| EBITDA | -13.21M |
| Net Income | -12.6M |
| Diluted EPS | -1.93 |
| Total Cash | 46.47M |
| Total Cash/Share | 6.04 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 8.92 |
| Book Value Per Share | 5.57 |
| 52-Week Change | -57.54 |
| 52-Week High | 2.22 |
| 52-Week Low | 0.55 |
| Moving Average 50 Days | 0.84 |
| Moving Average 200 Days | 1.07 |
| Average Volume | 370,249 |
| Shares Outstanding | 6.49M |
| % Held by Institutions | 34.32 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | February 13, 2023 |